Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
Guardado en:
Autores principales: | Jacob E Choby, Tugba Ozturk, Sarah W Satola, Jesse T Jacob, David S Weiss |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f90525ab70e4605bd217ae9a096e2fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Carbapenem-Resistant <italic toggle="yes">Klebsiella pneumoniae</italic> Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
por: Victor I. Band, et al.
Publicado: (2018) -
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant
<i>Enterobacterales</i>
in the United States
por: Victor I. Band, et al.
Publicado: (2021) -
Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance.
por: Victor I Band, et al.
Publicado: (2021) -
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Feiyang Zhang, et al.
Publicado: (2021) -
Does the COVID-19 pandemic reveal challenges for open science and the credibility of scientific dissemination?
por: Maria G. NOVAES, et al.
Publicado: (2020)